Treatment Response and Survival in Methamphetamine‐Associated Pulmonary Arterial Hypertension
Background Methamphetamine‐associated pulmonary arterial hypertension (Meth‐PAH) represents a growing subset of PAH. Relative to idiopathic PAH (iPAH), it is unknown whether patients with Meth‐PAH treated with continuous prostacyclin have similar outcomes and treatment response. The aims of this ana...
Gorde:
| Egile Nagusiak: | , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Wiley
2025-11-01
|
| Saila: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Gaiak: | |
| Sarrera elektronikoa: | https://www.ahajournals.org/doi/10.1161/JAHA.125.042673 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|